Resapp Health

Resapp Health Depreciation & Amortization

The Depreciation & Amortization of Resapp Health (RAP.AX) as of Oct 10, 2026 is 159,100.00 AUD. In the previous year, Depreciation & Amortization was 288,400.00 AUD — a change of -44.83% (lower).

Depreciation & Amortization

159,100.00AUD

YoY

-44.83%

Last updated:

Depreciation & Amortization of Resapp Health is 2022 159,100.00 AUD. Depreciation & Amortization of Resapp Health was 2021 288,400.00 AUD. It decreases by -44.83% lower compared to the previous year.

The Resapp Health Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2017
269,800.00 AUD
Jan 1, 2018
134,900.00 AUD
Jan 1, 2019
140,200.00 AUD
Jan 1, 2020
247,400.00 AUD
Jan 1, 2021
288,400.00 AUD
Jan 1, 2022
159,100.00 AUD
The Resapp Health Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
159,100.00AUD-44.83%
288,400.00AUD+16.57%
247,400.00AUD+76.46%
140,200.00AUD+3.93%
134,900.00AUD-50.00%
269,800.00AUD—
Access this data via the Eulerpool API

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Resapp Health stock

Depreciation & Amortization of Resapp Health is 159,100.00 AUD in 2022.

Depreciation & Amortization of Resapp Health changed from 288,400.00 AUD to 159,100.00 AUD, representing a -44.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Resapp Health since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Resapp Health historically and in real time.

Access this data via the Eulerpool API

Income Statement — Resapp Health

All Key Metrics — Resapp Health